Aspirin Versus Anticoagulation for Prevention of Venous Thromboembolism Major Lower Extremity Orthopedic Surgery: a Systematic Review and Meta-Analysis
Total Page:16
File Type:pdf, Size:1020Kb
ORIGINAL RESEARCH Aspirin Versus Anticoagulation for Prevention of Venous Thromboembolism Major Lower Extremity Orthopedic Surgery: A Systematic Review and Meta-Analysis Frank S. Drescher, MD1*, Brenda E. Sirovich, MD, MS2, Alexandra Lee, MS3, Daniel H. Morrison, MD, MS4, Wesley H. Chiang, MS2, Robin J. Larson, MD, MPH2 1Geisel School of Medicine at Dartmouth, Pulmonary and Critical Care Medicine, Veterans Affairs Medical Center, White River Junction, Vermont; 2Geisel School of Medicine at Dartmouth, and the Dartmouth Institute for Health Policy and Clinical Practice, Center for Education, Lebanon, New Hampshire; 3Herbert Wertheim College of Medicine at Florida International University, Miami, Florida; 4Geisel School of Medicine at Dartmouth, Sec- tion of Otolaryngology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. BACKGROUND: Hip fracture surgery and lower extremity screened participants for deep venous thrombosis (DVT). arthroplasty are associated with increased risk of both Overall rates of DVT did not differ statistically between aspi- venous thromboembolism and bleeding. The best pharma- rin and anticoagulants (relative risk [RR]: 1.15 [95% confi- cologic strategy for reducing these opposing risks is dence interval {CI}: 0.68–1.96]). Subgrouped by type of uncertain. surgery, there was a nonsignificant trend favoring anticoa- gulation following hip fracture repair but not knee or hip PURPOSE: To compare venous thromboembolism (VTE) arthroplasty (hip fracture RR: 1.60 [95% CI: 0.80–3.20], 2 tri- and bleeding rates in adult patients receiving aspirin versus als; arthroplasty RR: 1.00 [95% CI: 0.49–2.05], 5 trials). The anticoagulants after major lower extremity orthopedic risk of bleeding was lower with aspirin than anticoagulants surgery. following hip fracture repair (RR: 0.32 [95% CI: 0.13–0.77], 2 DATA SOURCES: Medline, Cumulative Index to Nursing trials), with a nonsignificant trend favoring aspirin after and Allied Health Literature, and the Cochrane Library arthroplasty (RR: 0.63 [95% CI: 0.33–1.21], 5 trials). Rates through June 2013; reference lists, ClinicalTrials.gov, and of pulmonary embolism were too low to provide reliable scientific meeting abstracts. estimates. STUDY SELECTION: Randomized trials comparing aspirin CONCLUSION: Compared with anticoagulation, aspirin to anticoagulants for prevention of VTE following major may be associated with higher risk of DVT following hip lower extremity orthopedic surgery. fracture repair, although bleeding rates were substantially DATA EXTRACTION: Two reviewers independently lower. Aspirin was similarly effective after lower extremity extracted data on rates of VTE, bleeding, and mortality. arthroplasty and may be associated with lower bleeding risk. Journal of Hospital Medicine 2014;9:579–585. VC 2014 DATA SYNTHESIS: Of 298 studies screened, 8 trials includ- Society of Hospital Medicine ing 1408 participants met inclusion criteria; all trials Each year in the United States, over 1 million adults ity and mortality for patients, as well as substantial undergo hip fracture surgery or elective total knee or costs to the healthcare system.6 Although VTE is con- hip arthroplasty.1 Although highly effective for sidered to be a preventable cause of hospital admis- improving functional status and quality of life,2,3 each sion and death,7,8 the postoperative setting presents a of these procedures is associated with a substantial particular challenge, as efforts to reduce clotting must risk of developing a deep vein thrombosis (DVT) or be balanced against the risk of bleeding. pulmonary embolism (PE).4,5 Collectively referred to Despite how common this scenario is, there is no as venous thromboembolism (VTE), these clots in the consensus regarding the best pharmacologic strategy. venous system are associated with significant morbid- National guidelines recommend “pharmacologic thromboprophylaxis,” leaving the clinician to select the specific agent.4,5 Explicitly endorsed options include aspirin, vitamin K antagonists (VKA), unfrac- *Address for correspondence and reprint requests: Frank Drescher, tionated heparin, fondaparinux, low-molecular-weight MD, Assistant Professor of Medicine, Geisel School of Medicine at Dart- heparin (LMWH) and IIa/Xa factor inhibitors. Among mouth, Pulmonary and Critical Care Medicine, Veterans Affairs Medical these, aspirin, the only nonanticoagulant, has been the Center,(111) 215 North Main Street, White River Junction, VT 05009; 4,9,10 Telephone: 802-295-9363; Fax: 802-291-6257; E-mail: source of greatest controversy. [email protected] Two previous systematic reviews comparing aspirin Additional Supporting Information may be found in the online version of to anticoagulation for VTE prevention found conflict- this article. ing results.11,12 In addition, both used indirect com- Received: February 12, 2014; Revised: May 9, 2014; Accepted: May 20, parisons, a method in which the intervention and 2014 2014 Society of Hospital Medicine DOI 10.1002/jhm.2224 comparison data come from different studies, and sus- 13,14 Published online in Wiley Online Library (Wileyonlinelibrary.com). ceptibility to confounding is high. We aimed to An Official Publication of the Society of Hospital Medicine Journal of Hospital Medicine Vol 9 | No 9 | September 2014 579 Drescher et al | VTE Prevention After Orthopedic Surgery overcome the limitations of prior efforts to address our inclusion criteria. We used exploded Medical Sub- this commonly encountered clinical question by con- ject Headings terms and key words to generate sets ducting a systematic review and meta-analysis of for “aspirin” and “major orthopedic surgery” themes, randomized controlled trials that directly compared then used the Boolean term, “AND,” to find their the efficacy and safety of aspirin to anticoagulants for intersection. VTE prevention in adults undergoing common high- risk major orthopedic surgeries of the lower Additional Search Methods extremities. We manually reviewed references of relevant articles and searched ClinicalTrials.gov to identify any MATERIAL AND METHODS ongoing studies or unpublished data. We further Review Protocol searched the following sources: American College of Prior to conducting the review, we outlined an Chest Physicians (ACCP) Evidence-Based Clinical 4,17 approach to identifying and selecting eligible studies, Practice Guidelines, American Academy of Ortho- 5 prespecified outcomes of interest, and planned sub- paedic Surgeons guidelines (AAOS), and annual group analyses. The meta-analysis was performed meeting abstracts of the American Academy of Ortho- 18 according to the Preferred Reporting Items for System- paedic Surgery, the American Society of Hematol- 19 20 atic Reviews and Meta-Analyses and Cochrane ogy, and the ACCP. guidelines.15,16 Study Selection Study Eligibility Criteria Two pairs of 2 reviewers independently scanned the We prespecified the following inclusion criteria: (1) titles and abstracts of identified studies, excluding only the design was a randomized controlled trial; (2) the those that were clearly not relevant. The same reviewers population consisted of patients undergoing major independently reviewed the full text of each remaining orthopedic surgery including hip fracture surgery or study to make final decisions about eligibility. total knee or hip arthroplasty; (3) the study compared Data Extraction and Quality Assessment aspirin to 1 or more anticoagulants: VKA, unfractio- Two reviewers independently extracted data from nated heparin, LMWH, thrombin inhibitors, pentasac- each included study and rendered judgments regarding charides (eg, fondaparinux), factor Xa/IIa inhibitors the methodological quality using the Cochrane Risk dosed for VTE prevention; (4) subjects were followed of Bias Tool.21 for at least 7 days; and (5) the study reported at least 1 prespecified outcome of interest. We allowed the use Data Synthesis of pneumatic compression devices, as long as devices We used Review Manager (RevMan 5.1) to calculate were used in both arms of the study. pooled risk ratios using the Mantel-Haenszel method and random-effects models, which take into account Outcome Measures the presence of variability among included stud- We designated the rate of proximal DVT (occurring ies.16,22 We also manually pooled absolute event rates in the popliteal vein and above) as the primary out- for each study arm using the study weights assigned in come of interest. Additional efficacy outcomes the pooled risk ratio models. included rates of PE, PE-related mortality, and all- cause mortality. We required that DVT and PE were Assessment of Heterogeneity and Reporting Biases diagnosed by venography, computed tomography We assessed statistical variability among the studies (CT) angiography of the chest, pulmonary angiogra- contributing to each summary estimate and considered phy, ultrasound Doppler of the legs, or ventilation/ studies unacceptably heterogeneous if the test for het- perfusion scan. We allowed studies that screened par- erogeneity P value was <0.10 or the I2 exceeded ticipants for VTE (including the use of fibrinogen leg 50%.14,16 We constructed funnel plots to assess for scanning). publication bias but had too few studies for reliable A bleeding event was defined as any need for post- interpretation. operative blood transfusion or otherwise clinically sig- nificant bleeding (eg, prolonged postoperative wound Subgroup Analyses bleeding). We further defined major bleeding as the We prespecified subgroup analyses based on the indica- requirement